{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T11:10:35Z","timestamp":1768648235132,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["CAMS 2021-I2M-1-004"],"award-info":[{"award-number":["CAMS 2021-I2M-1-004"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cmi.2024.03.035","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T12:27:59Z","timestamp":1712579279000},"page":"1190-1196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of high-performance human papillomavirus testing to improve cervical cancer screening in China: a prospective population-based multicentre cohort study"],"prefix":"10.1016","volume":"30","author":[{"given":"Jian","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaokai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xibin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.03.035_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cmi.2024.03.035_bib2","first-page":"70","article-title":"Incidence and mortality of cervical cancer in China in 2015","volume":"2","author":"Gu","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.cmi.2024.03.035_bib3","first-page":"2","article-title":"Cancer incidence and mortality in China, 2015","volume":"1","author":"Zhang","year":"2021","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.cmi.2024.03.035_bib4","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.3802\/jgo.2016.27.e21","article-title":"Clinical significance of human papillomavirus genotyping","volume":"27","author":"Choi","year":"2016","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.cmi.2024.03.035_bib5","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1158\/1055-9965.EPI-10-0424","article-title":"Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix","volume":"19","author":"Sundstrom","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cmi.2024.03.035_bib6","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/cncr.30667","article-title":"Cervical cancer: a global health crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2024.03.035_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(18)32849-6","article-title":"Cervical cancer prevention in China: a key to cancer control","volume":"393","author":"Zhao","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.03.035_bib8","series-title":"Reaching 2030 cervical cancer elimination targets-New WHO recommendations for screening and treatment of cervical pre-cancer","year":"2021"},{"key":"10.1016\/j.cmi.2024.03.035_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cmi.2024.03.035_bib10","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.03.035_bib11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.03.035_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cmi.2024.03.035_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bpobgyn.2020.02.008","article-title":"Primary HPV screening for cervical cancer","volume":"65","author":"Bhatla","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.cmi.2024.03.035_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.03.035_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","article-title":"2020 list of human papillomavirus assays suitable for primary cervical cancer screening","volume":"27","author":"Arbyn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.03.035_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cmi.2024.03.035_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcv.2018.09.012","article-title":"The Valgent4 protocol: robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium","volume":"108","author":"Bonde","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cmi.2024.03.035_bib18","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/JCM.01282-17","article-title":"Evaluation of the clinical performance of the HPV-risk assay using the VALGENT-3 panel","volume":"55","author":"Polman","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cmi.2024.03.035_bib19","series-title":"Guidelines for the technical review of human papillomavirus (HPV) nucleic acid detection and genotyping reagents","year":"2015"},{"key":"10.1016\/j.cmi.2024.03.035_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00234-20","article-title":"Evaluation and optimization of the clinical accuracy of Hybribio's 14 High-Risk HPV with 16\/18 genotyping assay within the VALGENT-3 framework","volume":"58","author":"Xu","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2024.03.035_bib21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/jmv.25451","article-title":"A direct comparison of four high-risk human papillomavirus tests versus the cobas test: detecting CIN2+ in low-resource settings","volume":"91","author":"Xue","year":"2019","journal-title":"J Med Virol"},{"key":"10.1016\/j.cmi.2024.03.035_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ijc.24717","article-title":"Incidence and outcome of acquisition of human papillomavirus infection in women with normal cytology\u2014a population-based cohort study from Taiwan","volume":"126","author":"Chao","year":"2010","journal-title":"Int J Cancer"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T03:44:39Z","timestamp":1756698279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1198743X24001666"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.03.035","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of high-performance human papillomavirus testing to improve cervical cancer screening in China: a prospective population-based multicentre cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}